{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:19:15Z","timestamp":1793452755790,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL146701"],"award-info":[{"award-number":["1R01HL146701"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R44HL167436"],"award-info":[{"award-number":["1R44HL167436"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-2137100"],"award-info":[{"award-number":["DGE-2137100"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["2023-SRL-2618"],"award-info":[{"award-number":["2023-SRL-2618"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["2019-FLG-3807"],"award-info":[{"award-number":["2019-FLG-3807"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["2021-SRL-2617"],"award-info":[{"award-number":["2021-SRL-2617"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005562","name":"North Carolina Biotechnology Center","doi-asserted-by":"publisher","award":["2021-TRG-6705"],"award-info":[{"award-number":["2021-TRG-6705"]}],"id":[{"id":"10.13039\/100005562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007703","name":"North Carolina State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ymthe.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T11:45:37Z","timestamp":1715082337000},"page":"2286-2298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in\u00a0vivo model"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-393X","authenticated-orcid":false,"given":"Abhichart","family":"Krissanaprasit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mihalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Meinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryssa","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanika","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-2059","authenticated-orcid":false,"given":"Thomas H.","family":"LaBean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.05.002_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.beha.2013.07.010","article-title":"New developments in parenteral anticoagulation for arterial and venous thromboembolism","volume":"26","author":"van Es","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fcvm.2015.00030","article-title":"Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art","volume":"2","author":"Thaler","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ymthe.2024.05.002_bib3","article-title":"Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2024.05.002_bib4","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"CHEST"},{"key":"10.1016\/j.ymthe.2024.05.002_bib5","series-title":"Heparin - A Century of Progress","first-page":"211","article-title":"Adverse Effects of Heparin","author":"Alban","year":"2012"},{"key":"10.1016\/j.ymthe.2024.05.002_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/rth2.12390","article-title":"Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome","volume":"4","author":"Riker","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.05.002_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ymthe.2024.05.002_bib8","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1053\/j.jvca.2021.10.008","article-title":"Protamine-Induced Coronary Graft Thrombosis: A Review","volume":"36","author":"Chandiramani","year":"2022","journal-title":"J.\u00a0Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.ymthe.2024.05.002_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: a review","volume":"16","author":"Harter","year":"2015","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.ymthe.2024.05.002_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/jcm7020029","article-title":"A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents","volume":"7","author":"Joppa","year":"2018","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ymthe.2024.05.002_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.002_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In\u00a0vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.05.002_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.05.002_bib14","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1038\/mtna.2014.32","article-title":"Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy","volume":"3","author":"Sun","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.05.002_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of aptamer discovery and technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ymthe.2024.05.002_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.05.002_bib17","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.ymthe.2024.05.002_bib18","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1021\/acsami.0c19562","article-title":"Functional Aptamer-Embedded Nanomaterials for Diagnostics and Therapeutics","volume":"13","author":"Xie","year":"2021","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.ymthe.2024.05.002_bib19","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1021\/acsami.0c17121","article-title":"Aptamer-Functionalized Micro- and Nanocarriers for Controlled Release","volume":"13","author":"V\u00e1zquez-Gonz\u00e1lez","year":"2021","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.ymthe.2024.05.002_bib20","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1021\/acsanm.0c01785","article-title":"Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review","volume":"3","author":"Ravichandran","year":"2020","journal-title":"ACS Appl. Nano Mat"},{"key":"10.1016\/j.ymthe.2024.05.002_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-bioeng-082020-035644","article-title":"Recent Advances in Aptamer-Based Biosensors for Global Health Applications","volume":"23","author":"Stanciu","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2024.05.002_bib22","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/molecules21121613","article-title":"Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications","volume":"21","author":"Vorobyeva","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2024.05.002_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejps.2012.10.014","article-title":"Therapeutic RNA aptamers in clinical trials","volume":"48","author":"Sundaram","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ymthe.2024.05.002_bib24","article-title":"Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib25","first-page":"263","article-title":"Pegaptanib in the treatment of wet, age-related macular degeneration","volume":"1","author":"Vinores","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ymthe.2024.05.002_bib26","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms22083897","article-title":"Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.05.002_bib27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nbt1023","article-title":"Antidote-mediated control of an anticoagulant aptamer in\u00a0vivo","volume":"22","author":"Rusconi","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ymthe.2006.04.006","article-title":"A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery","volume":"14","author":"Nimjee","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.002_bib29","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.106.668434","article-title":"First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology","volume":"114","author":"Dyke","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2024.05.002_bib30","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.107.745687","article-title":"Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease","volume":"117","author":"Chan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2024.05.002_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1538-7836.2008.02932.x","article-title":"A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor","volume":"6","author":"Chan","year":"2008","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.05.002_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCULATIONAHA.109.927756","article-title":"First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention","volume":"122","author":"Cohen","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2024.05.002_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ahj.2010.10.022","volume":"161","author":"Povsic","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2024.05.002_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.05.002_bib35","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","article-title":"Pre-existing anti\u2013polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer","volume":"137","author":"Ganson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature04586","article-title":"Folding DNA to create nanoscale shapes and patterns","volume":"440","author":"Rothemund","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.05.002_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature07971","article-title":"Self-assembly of a nanoscale DNA box with a controllable lid","volume":"459","author":"Andersen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.05.002_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nature08016","article-title":"Self-assembly of DNA into nanoscale three-dimensional shapes","volume":"459","author":"Douglas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.05.002_bib39","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/ar500076k","article-title":"RNA Self-Assembly and RNA Nanotechnology","volume":"47","author":"Grabow","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ymthe.2024.05.002_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2015.162","article-title":"Complex wireframe DNA origami nanostructures with multi-arm junction vertices","volume":"10","author":"Zhang","year":"2015","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature14586","article-title":"DNA rendering of polyhedral meshes at the nanoscale","volume":"523","author":"Benson","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.05.002_bib42","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1039\/C6NR03199D","article-title":"Protein patterning by a DNA origami framework","volume":"8","author":"Aslan","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ymthe.2024.05.002_bib43","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1039\/C8CC00738A","article-title":"Gene assembly via one-pot chemical ligation of DNA promoted by DNA nanostructures","volume":"54","author":"Manuguerra","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ymthe.2024.05.002_bib44","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1021\/acs.chemrev.6b00825","article-title":"DNA Origami: Scaffolds for Creating Higher Order Structures","volume":"117","author":"Hong","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ymthe.2024.05.002_bib45","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41467-018-04652-4","article-title":"In\u00a0vivo production of RNA nanostructures via programmed folding of single-stranded RNAs","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.05.002_bib46","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1021\/acsnano.9b06466","article-title":"Extrusion of RNA from a DNA-Origami-Based Nanofactory","volume":"14","author":"Hahn","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.05.002_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules21020202","article-title":"Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures","volume":"21","author":"Rangnekar","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ymthe.2024.05.002_bib48","doi-asserted-by":"crossref","first-page":"14423","DOI":"10.1002\/anie.201706765","article-title":"Docking of Antibodies into the Cavities of DNA Origami Structures","volume":"56","author":"Ouyang","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ymthe.2024.05.002_bib49","doi-asserted-by":"crossref","first-page":"12301","DOI":"10.1021\/acsnano.9b06522","article-title":"Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology","volume":"13","author":"Panigaj","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.05.002_bib50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nnano.2015.190","article-title":"Routing of individual polymers in designed patterns","volume":"10","author":"Knudsen","year":"2015","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib51","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1126\/science.aaz7440","article-title":"Precise pitch-scaling of carbon nanotube arrays within three-dimensional DNA nanotrenches","volume":"368","author":"Sun","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.002_bib52","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/app11052245","article-title":"Mechanical and Electrical Properties of DNA Hydrogel-Based Composites Containing Self-Assembled Three-Dimensional Nanocircuits","volume":"11","author":"Gao","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ymthe.2024.05.002_bib53","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nbt.4071","article-title":"A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in\u00a0vivo","volume":"36","author":"Li","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib54","first-page":"503","article-title":"Multiplexed DNA detection with DNA tweezers in a one-pot reaction","volume":"2","author":"Lertanantawong","year":"2019","journal-title":"Mater. Sci. Energy Technol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1452","article-title":"RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications","volume":"9","author":"Haque","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.ymthe.2024.05.002_bib56","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/acsnano.0c00602","article-title":"RNA Origami Nanostructures for Potent and Safe Anticancer Immunotherapy","volume":"14","author":"Qi","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2024.05.002_bib57","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1021\/acs.chemrev.0c01332","article-title":"Self-Assembling Nucleic Acid Nanostructures Functionalized with Aptamers","volume":"121","author":"Krissanaprasit","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ymthe.2024.05.002_bib58","article-title":"DNA aerogels and DNA-wrapped CNT aerogels for neuromorphic applications","volume":"16","author":"Hosseini","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ymthe.2024.05.002_bib59","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.1253920","article-title":"A single-stranded architecture for cotranscriptional folding of RNA nanostructures","volume":"345","author":"Geary","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.002_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41467-017-02435-x","article-title":"Development of a genetically encodable FRET system using fluorescent RNA aptamers","volume":"9","author":"Jepsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.05.002_bib61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/nano9040507","article-title":"Out-of-Plane Aptamer Functionalization of RNA Three-Helix Tiles","volume":"9","author":"Chopra","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ymthe.2024.05.002_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808262","article-title":"Genetically Encoded, Functional Single-Strand RNA Origami: Anticoagulant","volume":"31","author":"Krissanaprasit","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2024.05.002_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001826","article-title":"Multivalent Aptamer-Functionalized Single-Strand RNA Origami as Effective, Target-Specific Anticoagulants with Corresponding Reversal Agents","volume":"10","author":"Krissanaprasit","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2024.05.002_bib64","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1538-7836.2012.04679.x","article-title":"A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity","volume":"10","author":"Bompiani","year":"2012","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2024.05.002_bib65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/mthe.2001.0495","article-title":"Generation of Species Cross-reactive Aptamers Using \u201cToggle\u201d SELEX","volume":"4","author":"White","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.002_bib66","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1261\/rna.1239308","article-title":"Crystal structure of an RNA aptamer bound to thrombin","volume":"14","author":"Long","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.ymthe.2024.05.002_bib67","article-title":"Synthetic Platelet Microgels Containing Fibrin Knob B Mimetic Motifs Enhance Clotting Responses","volume":"4","author":"Nandi","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ymthe.2024.05.002_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib69","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/cbic.200700535","article-title":"Multidomain targeting generates a high-affinity thrombin-inhibiting bivalent aptamer","volume":"18","author":"M\u00fcller","year":"2007","journal-title":"ChemBioChem."},{"key":"10.1016\/j.ymthe.2024.05.002_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nano.2011.08.011","article-title":"Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures","volume":"8","author":"Rangnekar","year":"2012","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ymthe.2024.05.002_bib71","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/cbic.201900265","article-title":"DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human \u03b1-Thrombin Aptamers with Potent Anticoagulant Activity","volume":"20","author":"Zhou","year":"2019","journal-title":"ChemBioChem."},{"key":"10.1016\/j.ymthe.2024.05.002_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41467-020-20638-7","article-title":"A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.05.002_bib73","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.omtn.2023.07.038","article-title":"A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice","volume":"33","author":"Nagano","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.05.002_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chembiol.2004.10.017","article-title":"Direct In\u00a0Vitro Selection of a 2\u2032-O-Methyl Aptamer to VEGF","volume":"12","author":"Burmeister","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.addr.2007.03.006","article-title":"RNA interference and innate immunity","volume":"59","author":"Sioud","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2024.05.002_bib76","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/eji.200535708","article-title":"Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: A central role for 2\u2032-hydroxyl uridines in immune responses","volume":"36","author":"Sioud","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.002_bib77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acscombsci.6b00073","article-title":"Cellular Delivery of RNA Nanoparticles","volume":"18","author":"Parlea","year":"2016","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ymthe.2024.05.002_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jcc.21596","article-title":"NUPACK: Analysis and design of nucleic acid systems","volume":"32","author":"Zadeh","year":"2011","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ymthe.2024.05.002_bib79","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.05.002_bib80","series-title":"DNA and RNA Origami: Methods and Protocols","first-page":"339","article-title":"Production and Testing of RNA Origami Anticoagulants","author":"Krissanaprasit","year":"2023"},{"key":"10.1016\/j.ymthe.2024.05.002_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/toxsci\/kfv114","article-title":"Nanoparticles Made From Xyloglucan-Block-Polycaprolactone Copolymers: Safety Assessment for Drug Delivery","volume":"147","author":"Mazzarino","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ymthe.2024.05.002_bib82","article-title":"Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs","volume":"73","author":"Evans","year":"2013","journal-title":"J. Vis. Exp."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:41:15Z","timestamp":1762548075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624003022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1525001624003022"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.002","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in\u00a0vivo model","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}